SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LPCN

Lipocine Inc. (NASDAQ:LPCN)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.43-0.01 (-0.69%)
 
Market cap
$11.8M
Insider Score
56 / 99
Health Score
40 Fair
Analyst consensus
Buy
Listed since
Oct 22, 2013
Website
lipocine.com
Insider Score
/ 100
LPCN Insider Score

Lipocine Inc. has a live Insider Score.

Scored on 3 qualifying trades from 1 insider in the last 90 days.

Unlock the score

LPCN investor presentations

LPCN 1144 NC Presentation for Bio 2025Latest
Oct 26, 2026 · Company IR page
Source Open

This presentation is the company’s own material, shown here with a link to where it was published. If you are LPCN and want it taken down, email george@insiderbuying.com and we will remove it within two business days.

Past presentations

LPCN 1144 Presentation LiFT Topline 36 Week Results 08 24 21 9 am
Oct 26, 2026 · Company IR page
Source Open
LPCN 1144 Presentation LiFT Topline 12 Week Results FINAL
Oct 26, 2026 · Company IR page
Source Open
LPCN 1107 PTB NC Presentation
Oct 26, 2026 · Company IR page
Source Open
LPCN 2101 Epilepsy Treatment NC Presentation
Oct 26, 2026 · Company IR page
Source Open
LPCN 1148 Liver Cirrhosis NC Presentation
Oct 26, 2026 · Company IR page
Source Open
LPCN 2401 Obesity Management NC Presentation
Oct 26, 2026 · Company IR page
Source Open
LPCN 1154 May 16 Conference Call Presentation 05 15 23 12 pm 002
Oct 26, 2026 · Company IR page
Source Open
LPCN 1154 PPD NC Presentation for April 2026
Oct 26, 2026 · Company IR page
Source Open
LPCN 2203 ET NC Presentation
Oct 26, 2026 · Company IR page
Source Open
LPCN 2201 MDD Nonconfidential Presentation 022226
Oct 26, 2026 · Company IR page
Source Open
Investor presentation — October 2026
Oct 20, 2026 · 42 pages · SEC filing
Source Open
Investor presentation — September 2026
Sep 16, 2026 · 22 pages · SEC filing
Source Open
Investor presentation — June 2026
Jun 12, 2026 · 46 pages · SEC filing
Source Open
Investor presentation — May 2026
May 26, 2026 · 15 pages · SEC filing
Source Open
Investor presentation — May 2026
May 7, 2026 · 58 pages · SEC filing
Source Open
Investor presentation — April 2026
Apr 2, 2026 · 47 pages · SEC filing
Source Open
Investor presentation — February 2026
Feb 18, 2026 · 44 pages · SEC filing
Source Open
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.